Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
VTRS
VIATRIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$23.44B$20.45-1.40%$2.76B-38.58x1.53
United States
BBTX
BAMBUSA THERAPEUTICS INC
NASDAQ
Biotechnology
N/A$16.352.32%N/AN/A-2.09
United States
VJET
FLYTE AVIATION INC
NYSEMKT
Medical Devices
$1.44M$0.42-4.51%-$24.03M-0.01x1.03
United States
ITGR
INTEGER HOLDINGS CORP
NYSE
Medical Devices
$4.32B$126.970.21%$296.08M42.18x0.97
United States
CUPR
CUPRINA HOLDINGS (CAYMAN) LTD
NASDAQ
Medical Instruments & Supplies
$4.53M$1.690.60%-$3.64M-1.17x0.68
Singapore
AIM
AIM IMMUNOTECH INC
NYSEMKT
Biotechnology
$5.43M$0.143.82%-$11.83M-0.08x0.38
United States
CCEL
CRYO CELL INTERNATIONAL INC
NYSEMKT
Medical Care Facilities
$37.33M$4.631.76%$1.27M-20.13x-4.80
United States
ABOS
ACUMEN PHARMACEUTICALS INC
NASDAQ
Biotechnology
$16.64M$0.236.48%-$99.53M-0.15x1.47
United States
CANF
CAN-FITE BIOPHARMA LTD
NYSEMKT
Biotechnology
$3.28M$1.53-1.92%N/AN/A0.66
Israel
ESLA
ESTRELLA IMMUNOPHARMA INC
NASDAQ
Biotechnology
$14.60M$0.33-12.63%-$12.59M-1.19x-1.12
United States
XBIO
XENETIC BIOSCIENCES INC
NASDAQ
Biotechnology
$3.77M$1.618.05%-$3.66M-1.04x0.43
United States
ADVB
ADVANCED BIOMED INC
NASDAQ
Diagnostics & Research
$3.47M$2.10-5.41%$6.06M0.39x0.14
United States
XTNT
XTANT MEDICAL HOLDINGS INC
NYSEMKT
Medical Devices
$28.76M$0.21-2.38%-$2.45M-2.56x0.99
United States
APVO
APTEVO THERAPEUTICS INC
NASDAQ
Biotechnology
$830.71k$0.46-16.03%-$24.58M0.01x1.40
United States
APRE
APREA THERAPEUTICS INC
NASDAQ
Biotechnology
$6.43M$0.4511.58%-$14.38M-0.69x0.14
United States
ACTU
ACTUATE THERAPEUTICS INC
NASDAQ
Biotechnology
$15.22M$0.25-5.97%-$18.45M-0.33x-4.98
United States
IMCC
IM CANNABIS CORP
NASDAQ
Drug Manufacturers - Specialty & Generic
$813.86k$0.49-0.20%-$8.90MN/A-5.61
Israel
BRTX
BIORESTORATIVE THERAPIES INC
NASDAQ
Biotechnology
$1.71M$1.34-5.63%-$10.85M-0.06x0.53
United States
ACON
ACLARION INC
NASDAQ
Health Information Services
$3.95M$1.37-1.44%-$9.86M-0.25x0.07
United States
CNSP
CNS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$6.07M$4.1519.25%-$16.67M-0.18x0.21
United States
COCH
ENVOY MEDICAL INC
NASDAQ
Medical Devices
$53.20M$6.87-0.72%-$20.55M-1.49x-13.26
United States
CODX
CO-DIAGNOSTICS INC
NASDAQ
Medical Devices
$2.06M$0.20-12.89%-$46.98M-0.01x0.36
United States
WOK
WORK MEDICAL TECHNOLOGY GROUP LTD
NASDAQ
Medical Devices
$20.56k$1.19-3.09%N/A-0.00x0.53
China
ALPS
ALPS GROUP INC
NASDAQ
Health Information Services
$38.94M$1.171.74%N/AN/A-3.49
United States
HCWB
HCW BIOLOGICS INC
NASDAQ
Biotechnology
$1.43M$0.78-2.88%-$4.10M-0.04x2.60
United States
ZJYL
JIN MEDICAL INTERNATIONAL LTD
NASDAQ
Medical Instruments & Supplies
$26.42M$3.38-7.02%$1.58M17.76x0.85
China
ICCC
IMMUCELL CORP
NASDAQ
Biotechnology
$103.01M$11.33-0.79%$4.09M59.63x0.46
United States
AIDX
20/20 BIOLABS INC
NASDAQ
Medical Devices
$2.62M$0.191.08%-$5.64M-0.20x4.66
United States
ADGM
ADAGIO MEDICAL HOLDINGS INC
NASDAQ
Medical Devices
$1.22M$1.652.48%-$23.19M-0.04x-82.65
United States
XTLB
XTL BIOPHARMACEUTICALS LTD
NASDAQ
Biotechnology
$4.60M$1.625.19%-$6.96M-0.51x-1.65
United States
GDTC
CYTOMED THERAPEUTICS LTD
NASDAQ
Biotechnology
$9.35M$0.781.16%-$2.37M-3.33x0.33
Singapore
EOCN
EOCENE LTD
NASDAQ
Biotechnology
$2.46M$2.46-2.77%N/A-0.16x0.44
Israel
ABVC
ABVC BIOPHARMA INC
NASDAQ
Biotechnology
$25.36M$0.940.00%-$3.26M-5.88x0.66
United States
ACH
ACCENDRA HEALTH INC
NYSE
Medical Distribution
$1.54M$0.02-76.74%$131.39M-0.01x-4.66
United States
AHG
AKSO HEALTH GROUP
NASDAQ
Medical Distribution
$1.06B$1.24-6.77%-$18.29M-41.33x0.05
China
ADXN
ADDEX THERAPEUTICS LTD
NASDAQ
Biotechnology
$3.57M$3.50-8.62%-$8.20M-72.92x0.82
Switzerland
IMMP
IMMUTEP LTD
NASDAQ
Biotechnology
$24.02M$3.26-4.12%-$55.76M-0.43x0.35
Australia
XAIR
BEYOND AIR INC
NASDAQ
Medical Devices
$3.35M$2.01-0.50%-$24.41M-0.05x5.66
United States
XCUR
EXICURE INC
NASDAQ
Biotechnology
$7.07M$1.080.93%-$8.55M-0.82x10.67
United States
XLO
XILIO THERAPEUTICS INC
NASDAQ
Biotechnology
$53.26M$7.54-2.08%-$10.17M12.57x0.98
United States
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
NASDAQ
Biotechnology
$1.23B$13.14-1.13%N/A-5.58x4.81
China
ACXP
ACURX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$6.00M$0.995.88%-$8.10M-0.51x0.41
United States
MGRX
MANGOCEUTICALS INC
NASDAQ
Health Information Services
$3.56M$0.160.00%-$9.34M-0.31x0.13
United States
PIII
P3 HEALTH PARTNERS INC
NASDAQ
Medical Care Facilities
$15.90M$2.19-9.13%$67.48M-0.09x4.37
United States
ITOC
ITONIC HOLDINGS LTD
NASDAQ
Medical Devices
$14.34M$1.964.26%-$8.76M-0.44x0.08
China
SILO
SILO PHARMA INC
NASDAQ
Biotechnology
$3.69M$1.718.57%-$3.67M-0.62x0.04
United States
TELO
TELOMIR PHARMACEUTICALS INC
NASDAQ
Biotechnology
$31.16M$0.42-12.06%-$5.47M-0.48x0.05
United States
KALA
KALA BIO INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$2.21M$3.43-10.44%-$8.70M-0.00x0.17
United States

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
607-1.06%-5.37%+1.47%-95.68%19.13x4.98x-21.90%-6.59%-2.48%+86.63%Strong Buy
50-0.56%-4.08%+2.00%+22.86%29.95x4.58x+578.29%+6.81%+12.39%+6.79%Buy
20-0.92%-1.40%+9.53%+26.33%43.43x8.56x+13.92%+10.56%+18.51%+3.46%Buy
74-0.28%-1.09%+4.24%-99.93%73.91x2.53x+6.35%+2.26%+23.82%+176.81%Buy
10-3.74%-0.24%+0.78%+37.52%16.67x2.36x+14.09%+4.30%+10.15%+12.60%Buy
49-2.20%-6.82%-2.04%-66.67%26.40x4.05x+9.20%+4.54%+9.98%+28.28%Buy
47-1.65%-1.44%+5.44%-63.41%16.07x5.96x-34.91%+7.80%+16.67%+10.43%Buy
132-0.60%-2.88%+4.78%-91.24%25.21x3.28x+9.38%+5.12%+9.42%+22.33%Buy
8-1.44%+0.31%+6.60%+19.33%28.92x-244.56x-64.09%+4.18%+25.36%+3.68%Buy
51-1.12%-2.22%+3.64%+10.29%28.23x3.59x+9.67%+7.36%+12.30%+12.60%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bausch Health Companies (NYSE:BHC)


Bausch Health Companies (NYSE:BHC) is the #1 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bausch Health Companies (NYSE:BHC) is: Value: A, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: C.

Bausch Health Companies (NYSE:BHC) has a Due Diligence Score of 9, which is -18 points lower than the healthcare sector average of 27. Although this number is below the industry average, our proven quant model rates BHC as a "A".It passed 3 out of 33 due diligence checks and has weak fundamentals. Bausch Health Companies has seen its stock return 38.17% over the past year, overperforming other healthcare stocks by 136 percentage points.

Bausch Health Companies has an average 1 year price target of $9.00, an upside of 6.26% from Bausch Health Companies's current stock price of $8.47.

Bausch Health Companies stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Bausch Health Companies, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Oscar Health (NYSE:OSCR)


Oscar Health (NYSE:OSCR) is the #2 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Oscar Health (NYSE:OSCR) is: Value: A, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Oscar Health (NYSE:OSCR) has a Due Diligence Score of 54, which is 27 points higher than the healthcare sector average of 27. It passed 18 out of 33 due diligence checks and has strong fundamentals. Oscar Health has seen its stock return 109.4% over the past year, overperforming other healthcare stocks by 207 percentage points.

Oscar Health has an average 1 year price target of $37.00, an upside of 23.99% from Oscar Health's current stock price of $29.84.

Oscar Health stock has a consensus Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Oscar Health, 25% have issued a Strong Buy rating, 12.5% have issued a Buy, 50% have issued a Hold, while 12.5% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Xeris Biopharma Holdings (NASDAQ:XERS)


Xeris Biopharma Holdings (NASDAQ:XERS) is the #3 top healthcare stock out of 1048 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 12 points higher than the healthcare sector average of 27. It passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 131.4% over the past year, overperforming other healthcare stocks by 229 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 1.19% from Xeris Biopharma Holdings's current stock price of $16.80.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 80 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)


Rallybio (NASDAQ:RLYB) has an annual dividend yield of 88.69%, which is 85 percentage points higher than the healthcare sector average of 3.57%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Supernus (NASDAQ:SUPN)


Supernus (NASDAQ:SUPN) has an annual dividend yield of 28%, which is 24 percentage points higher than the healthcare sector average of 3.57%.

Supernus's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)


Cumberland Pharmaceuticals (NASDAQ:CPIX) has an annual dividend yield of 25.86%, which is 22 percentage points higher than the healthcare sector average of 3.57%.

Cumberland Pharmaceuticals's dividend payout ratio of 65.4% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.13% in the last day, and down -3.49% over the last week. Cue Biopharma was the among the top losers in the healthcare sector, dropping -79.93% yesterday.

Cue Biopharma shares are trading lower after the company reported worse-than-expected Q3 financial results.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 69 points higher than the healthcare sector average of 17. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 55.59% in the past year. It has overperformed other stocks in the healthcare sector by 154 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -2.88% in the past year. It has overperformed other stocks in the healthcare sector by 95 percentage points.

3. Embecta (NASDAQ:EMBC)


Embecta (NASDAQ:EMBC) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 40 points higher than the healthcare sector average of 17. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -57.02% in the past year. It has overperformed other stocks in the healthcare sector by 41 percentage points.

Are healthcare stocks a good buy now?

57.43% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 40.04% over the next year.

5.44% of healthcare stocks have a Zen Rating of A (Strong Buy), 14.12% of healthcare stocks are rated B (Buy), 45.98% are rated C (Hold), 25.65% are rated D (Sell), and 8.81% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 33.91x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.